Skip to main content

Table 2 Stenting data

From: In vivo measurement of stent length by using intravascular ultrasound

  Lesions (n = 95)
Lesion site (%)LAD55 (57.9)
LCX18 (18.9)
RCA22 (23.2)
Lesion typea (%)Low risk41 (43.2)
Moderate risk46 (48.4)
High risk8 (8.4)
Lesion length, mm 9.09 (7.0–13.25)
Reference diameter, mm 3.13 ± 0.64
Prestent MLD, mm 0.82 ± 0.32
Prestent diameter stenosis (%) 63.06 ± 14.87
Poststent MLD, mm 2.56 ± 0.44
Poststent diameter stenosis (%) 10.49 ± 5.50
Drug-eluting stent (%) 38 (40)
Bare metal stent (%) 57 (60)
Stent diameter, mm (%)2.5 mm14 (14.74)
3.0 mm54 (56.84)
3.5 mm23 (24.21)
4.0 mm4 (4.21)
Stent length, mm (%)8.0 mm2 (2.1)
9.0 mm2 (2.1)
12.0 mm5 (5.3)
13.0 mm4 (4.2)
15.0 mm18 (18.9)
18.0 mm32 (33.7)
20.0 mm3 (3.2)
23.0 mm18 (18.9)
24.0 mm3 (3.2)
25.0 mm1 (1.1)
28.0 mm6 (6.3)
30.0 mm1 (1.1)
Stent strut (wire) thickness, mm 0.14 (13.0–16.0)
Stent deployment pressure, atm 16.0 (14.0–18.0)
Poststent balloon dilatation (%) 19 (20%)
  1. Data are given as mean ± SD, percentage, or median (IQR)
  2. LAD left anterior descending artery, LCX left circumflex artery, MLD minimal lumen diameter, RCA right coronary artery
  3. aAmerican College of Cardiology/American Heart Association (ACC/AHA) classification [10]
  4. p < 0.0001 (compared with the prestent measurements)